254 related articles for article (PubMed ID: 21848990)
1. Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses.
Nijenhuis CM; ter Horst PG; van Rein N; Wilffert B; de Jong-van den Berg LT
Br J Clin Pharmacol; 2012 Jan; 73(1):126-34. PubMed ID: 21848990
[TBL] [Abstract][Full Text] [Related]
2. Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1: Literature review.
Nijenhuis CM; Horst PG; Berg LT; Wilffert B
Br J Clin Pharmacol; 2012 Jan; 73(1):16-26. PubMed ID: 21815911
[TBL] [Abstract][Full Text] [Related]
3. In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children.
ter Horst PG; Bos HJ; de Jong-van de Berg LT; Wilffert B
Eur J Clin Pharmacol; 2013 Mar; 69(3):541-7. PubMed ID: 22815049
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants and the developing nervous system.
Warren JB
Br J Clin Pharmacol; 2012 Jan; 73(1):1-3. PubMed ID: 21955357
[No Abstract] [Full Text] [Related]
5. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.
Davis RL; Rubanowice D; McPhillips H; Raebel MA; Andrade SE; Smith D; Yood MU; Platt R;
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1086-94. PubMed ID: 17729378
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
Taylor D
Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
[TBL] [Abstract][Full Text] [Related]
8. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.
Peet M
Br J Psychiatry; 1994 Apr; 164(4):549-50. PubMed ID: 8038948
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in antidepressant drug response.
Keers R; Aitchison KJ
Int Rev Psychiatry; 2010; 22(5):485-500. PubMed ID: 21047161
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
11. Tricyclic antidepressants in pregnancy and puerperium.
Gentile S
Expert Opin Drug Saf; 2014 Feb; 13(2):207-25. PubMed ID: 24383525
[TBL] [Abstract][Full Text] [Related]
12. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
13. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.
Ban L; Gibson JE; West J; Fiaschi L; Sokal R; Smeeth L; Doyle P; Hubbard RB; Tata LJ
BJOG; 2014 Nov; 121(12):1471-81. PubMed ID: 24612301
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
[TBL] [Abstract][Full Text] [Related]
15. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
[TBL] [Abstract][Full Text] [Related]
19. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
20. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
